Yilan Li
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Molecular Medicine top 10%
Papers in
-
- Heart Failure Treatment and Management 4
- Co-authors
- Yao Zhang (16 shared papers)Neil F. Shay (3 shared papers)Qiang Luo (6 shared papers)Ning Wang (6 shared papers)Xiaobing Huo (4 shared papers)Yunhong Li (4 shared papers)Orsolya Mezei (2 shared papers)Qinlong Jing (6 shared papers)
- Journals
- Frontiers in Bioengineering and Biotechnology (3 papers)The Journal of Clinical Endocrinology & Metabolism (3 papers)Frontiers in Pharmacology (3 papers)Journal of Nutrition (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaUnited StatesHungary
In The Last Decade
Yilan Li
86 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 148
- Infectious Diseases 222
- Molecular Medicine 57
- Modeling and Simulation 52
- Cancer Research 138
- Health 74
Countries citing papers authored by Yilan Li
This map shows the geographic impact of Yilan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yilan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yilan Li more than expected).
Fields of papers citing papers by Yilan Li
This network shows the impact of papers produced by Yilan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yilan Li. The network helps show where Yilan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yilan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 163 | |
| 2 | 2012 | 80 | |
| 3 | 2009 | 63 | |
| 4 | 2006 | 58 | |
| 5 | 2022 | 56 | |
| 6 | 2022 | 54 | |
| 7 | 2022 | 53 | |
| 8 | 2013 | 51 | |
| 9 | 2019 | 47 | |
| 10 | 2016 | 46 | |
| 11 | 2022 | 41 | |
| 12 | 2022 | 39 | |
| 13 | 2022 | 39 | |
| 14 | 2021 | 38 | |
| 15 | 2020 | 32 | |
| 16 | 2024 | 30 | |
| 17 | 2023 | 26 | |
| 18 | 2015 | 25 | |
| 19 | 2019 | 22 | |
| 20 | 2021 | 21 |
About Yilan Li
Yilan Li is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Epidemiology, Endocrinology, Diabetes and Metabolism and Infectious Diseases, having authored 96 papers that have together received 1.5k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (6 papers), Viral Infections and Vectors (5 papers), Geochemistry and Elemental Analysis (4 papers), Heart Failure Treatment and Management (4 papers), Ferroptosis and cancer prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Advanced Nanomaterials in Catalysis (4 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Infectious Diseases (222 citations), Molecular Medicine (57 citations), Modeling and Simulation (52 citations), Cancer Research (138 citations) and Health (74 citations). Yilan Li has collaborated with scholars based in China, United States and Hungary. Frequent co-authors include Yao Zhang, Neil F. Shay, Qiang Luo, Ning Wang, Xiaobing Huo, Yunhong Li, Orsolya Mezei, Qinlong Jing, Marie‐Louise Ricketts and Shipeng Chen. Their work appears in journals such as Frontiers in Bioengineering and Biotechnology, The Journal of Clinical Endocrinology & Metabolism, Frontiers in Pharmacology, Journal of Nutrition and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.